SCHEMBL23838524

SCHEMBL23838524

CCCCC(CCC)c1nnc(C)o1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GPR88 Q9GZN0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20374168 0.96 CTSA (0.31) —
SCHEMBL22454232 0.93 LMNA (0.31) —
SCHEMBL22215301 0.79 DNM1 (0.39) —
SCHEMBL19630903 0.75 GPR88 (0.34) GPR88
SCHEMBL26778526 0.71 — —
SCHEMBL20824832 0.70 OPRM1 (0.34) —
SCHEMBL13319544 0.69 PKM (0.39) —
SCHEMBL25018018 0.69 — —
SCHEMBL25017825 0.69 MAPT (0.35) —
SCHEMBL25017202 0.69 MAPT (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3565807-B1 OXADIAZOLE INHIBITORS OF HIPK2 FOR TREATING KIDNEY FIBROSIS ICAHN SCHOOL MED MOUNT SINAI (US) 2021-09-22 — — EP disclosed
Send feedback